Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors ; volume:106 ; number:3-4 ; year:2021 ; pages:123-136 ; extent:14
Pharmacology ; 106, Heft 3-4 (2021), 123-136 (gesamt 14)
- Creator
-
König, David
Läubli, Heinz
- DOI
-
10.1159/000509081
- URN
-
urn:nbn:de:101:1-2021040100140688316744
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- König, David
- Läubli, Heinz
Other Objects (12)
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis